IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
IMPL
Delisted
IMPL was delisted on the 15th of December, 2023.
42 hedge funds and large institutions have $95.7M invested in Impel Pharmaceuticals Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Holders
42
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$707K | |
| 2 | +$255K | |
| 3 | +$211K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$210K |
| 5 |
State Street
Boston,
Massachusetts
|
+$70.8K |
Top Sellers
| 1 | -$1.8M | |
| 2 | -$1.23M | |
| 3 | -$504K | |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$153K |
| 5 |
Millennium Management
New York
|
-$128K |